Abstract
The ongoing development of manufacturing technologies and of biocompatible and biodegradable polymers have significantly contributed to the progress of drug delivery systems. In the last decades, the knowledge on keratins has significantly increased, regarding their ultrastructure, molecular and cell biology, physiological and pathological roles, as well as their practical applications in the biomedical field. Produced through sustainable, simple and cheap methods, the natural, non-toxic keratin is one of the raw biomaterials frequently used in the pharmaceutical technology for different applications. The purpose of this review is to present the keratins ultrastructure, types, biological distribution, tissue expression profiles, some of their multiple physiological and pathological roles, as well as their practical applications in drug delivery and cellular and tissue engineering.
Keywords: Drug delivery, keratin, modern systems, nanobiotechnology, pharmaceutical technology, sustainability.
Current Drug Targets
Title:Keratin-Based Biomaterials for Biomedical Applications
Volume: 15 Issue: 5
Author(s): George Dan Mogosanu, Alexandru Mihai Grumezescu and Mariana Carmen Chifiriuc
Affiliation:
Keywords: Drug delivery, keratin, modern systems, nanobiotechnology, pharmaceutical technology, sustainability.
Abstract: The ongoing development of manufacturing technologies and of biocompatible and biodegradable polymers have significantly contributed to the progress of drug delivery systems. In the last decades, the knowledge on keratins has significantly increased, regarding their ultrastructure, molecular and cell biology, physiological and pathological roles, as well as their practical applications in the biomedical field. Produced through sustainable, simple and cheap methods, the natural, non-toxic keratin is one of the raw biomaterials frequently used in the pharmaceutical technology for different applications. The purpose of this review is to present the keratins ultrastructure, types, biological distribution, tissue expression profiles, some of their multiple physiological and pathological roles, as well as their practical applications in drug delivery and cellular and tissue engineering.
Export Options
About this article
Cite this article as:
Mogosanu Dan George, Grumezescu Mihai Alexandru and Chifiriuc Carmen Mariana, Keratin-Based Biomaterials for Biomedical Applications, Current Drug Targets 2014; 15 (5) . https://dx.doi.org/10.2174/1389450115666140307154143
DOI https://dx.doi.org/10.2174/1389450115666140307154143 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy
Current Pharmaceutical Design Focus on MicroRNAs as Biomarker in Pediatric Diseases
Current Pharmaceutical Design Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?
Current Cancer Drug Targets Towards Characteristics of Photodynamic Drugs Specifically Aimed at Microvascular Diseases
Mini-Reviews in Medicinal Chemistry Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets FoxO Proteins: Regulation and Molecular Targets in Liver Cancer
Current Medicinal Chemistry Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Tumor Activity and Underlying Mechanism of Phomoxanthone B in MCF7 Cells
Anti-Cancer Agents in Medicinal Chemistry Molecular Targeting of Cell Death Signal Transduction Pathways in Cancer
Current Signal Transduction Therapy ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas
Current Cancer Drug Targets Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy
Current Cancer Drug Targets Current Management of Neonatal Soft-tissue Sarcomas and Benign Tumors with Local Aggressiveness
Current Pediatric Reviews Molecular Pathology of Sarcomas
Reviews on Recent Clinical Trials ras Genes and Human Cancer: Different Implications and Different Roles
Current Genomics Predicting the Druggability of Protein-Protein Interactions Based on Sequence and Structure Features of Active Pockets
Current Pharmaceutical Design Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
Recent Patents on Anti-Cancer Drug Discovery Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice
Current Molecular Medicine FOXO Transcription Factors and their Role in Disorders of the Female Reproductive Tract
Current Drug Targets The Use of Microarrays to Study Childhood Developmental Brain Disorders
Current Genomics